1. Home
  2. AIFF vs PLUR Comparison

AIFF vs PLUR Comparison

Compare AIFF & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIFF
  • PLUR
  • Stock Information
  • Founded
  • AIFF 2006
  • PLUR 2001
  • Country
  • AIFF United States
  • PLUR Israel
  • Employees
  • AIFF N/A
  • PLUR N/A
  • Industry
  • AIFF
  • PLUR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AIFF
  • PLUR Health Care
  • Exchange
  • AIFF NYSE
  • PLUR Nasdaq
  • Market Cap
  • AIFF 41.5M
  • PLUR 41.9M
  • IPO Year
  • AIFF N/A
  • PLUR N/A
  • Fundamental
  • Price
  • AIFF $2.74
  • PLUR $3.96
  • Analyst Decision
  • AIFF
  • PLUR Strong Buy
  • Analyst Count
  • AIFF 0
  • PLUR 1
  • Target Price
  • AIFF N/A
  • PLUR $12.00
  • AVG Volume (30 Days)
  • AIFF 1.4M
  • PLUR 10.9K
  • Earning Date
  • AIFF 08-18-2025
  • PLUR 05-13-2025
  • Dividend Yield
  • AIFF N/A
  • PLUR N/A
  • EPS Growth
  • AIFF N/A
  • PLUR N/A
  • EPS
  • AIFF N/A
  • PLUR N/A
  • Revenue
  • AIFF $139,000.00
  • PLUR $1,034,000.00
  • Revenue This Year
  • AIFF N/A
  • PLUR $472.39
  • Revenue Next Year
  • AIFF N/A
  • PLUR $254.29
  • P/E Ratio
  • AIFF N/A
  • PLUR N/A
  • Revenue Growth
  • AIFF N/A
  • PLUR 203.23
  • 52 Week Low
  • AIFF $1.86
  • PLUR $3.33
  • 52 Week High
  • AIFF $17.20
  • PLUR $7.13
  • Technical
  • Relative Strength Index (RSI)
  • AIFF 36.25
  • PLUR 37.09
  • Support Level
  • AIFF $3.03
  • PLUR $4.04
  • Resistance Level
  • AIFF $3.21
  • PLUR $4.50
  • Average True Range (ATR)
  • AIFF 0.25
  • PLUR 0.40
  • MACD
  • AIFF -0.04
  • PLUR -0.05
  • Stochastic Oscillator
  • AIFF 3.74
  • PLUR 7.03

About AIFF FIREFLY NEUROSCIENCE INC

Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

Share on Social Networks: